Nutex Health closed at $193.64 on Nov 5, down 5.64%, 13.9% below its 52-week closing high. Volume of 148.4K shares was 1.07× its 20-day average (close to normal).
Split-adjusted performance: -9.1% over one month, +43.9% over six months, +52.8% over one year.
In the quarter ended Jun 30, 2026, revenue was $210.75M, down 13.6% from a year earlier, with a net margin of 31.2%.
Short interest was 1.2M shares at the Oct 15 settlement, down 1.1% from the prior report (28.4% of float, 7.6 days to cover).